NextGen unveils products in Europe
NextGen Sciences of the UK has launched two new technologies that it maintains have the potential to revolutionise protein research and accelerate drug discovery.
NextGen Sciences of the UK has launched two new technologies that it maintains have the potential to revolutionise protein research and accelerate drug discovery.
Affymetrix is taking orders for a new one-chip product that offers researchers the protein-coding content of the human genome on a single microarray.
SAFLINK, a US company that develops biometric security products, has made its first sale of the technology to an unnamed pharmaceutical client.
BASF has started work on a combined heat and power plant at its site in Ludwigshafen that will help the company meet its long-term environmental targets.
CalbaTech has signed an agreement to acquire privately-held Molecula Research Laboratories, a company developing gene silencing technologies for gene and protein function studies.
Serono has initiated Phase I clinical testing of TACI-Ig, a soluble receptor-based drug that may have a role to play in the management of autoimmune diseases.
Inpharmatica of the UK has appointed a team of medicinal chemists that will operate at its new Cambridge laboratory, acquired in June from Arqule.
Ytron-Quadro officially launched its new Quadro Comil model U5, a scaleable laboratory model conical screen mill, at last week's PPMA 2003 show in Brimingham, UK.